COVID-19 second wave: Plea in SC seeks establishment of oxygen plants in all 738 districts with PM-CARES fund

-

New Delhi: A PIL has been filed in the Supreme Court seeking various relief measures for the country, including immediate procurement of COVID-19 vaccines and installation of a liquid medical oxygen (LMO) plant in each of the 738 districts using donations received under the PM-CARES fund.

The petitioner has made the Centre, the National Disaster Management Authority (NDMA), the Prime Minister's Citizen Assistance and Relief in Emergency Situation (PM-CARES) fund and all states as parties in the plea.

Follow LIVE updates on COVID-19 here

"Direct (PM-CARES fund) to first fund...for immediate procurement (by importing and/or otherwise) of (a) COVID-19 Vaccine; (b) oxygen plants/generators...and forthwith installation thereof in 738 district government hospitals throughout the country," the plea filed by lawyer Viplava Sharma said, adding that poor citizens should get oxygen free of cost.

The plea, which may come up for hearing next week, has also sought a direction to the Centre and states to ensure that all private and charitable hospitals also install plants for producing medical oxygen.

It has sought direction to states and union territories to set up electric and other crematoriums in all cities and also maintain and improve the condition of existing electric crematoriums.

The plea said that members of Parliament and Legislative Assemblies be directed to spend their fund in a disciplined manner with full transparency to serve their constituencies.

The petition challenged the 24 April notification issued by the Centre to the extent it capped the exemption from import duty granted to medical equipment for a period of three months only.

"Three month time period is too short a period from the standpoint of logistics involved in importing these highly sophisticated medical equipment in India by over 300 concerned notable hospitals throughout the country," it added.

The petition stated, "The Central, all the State and the UT governments as named and other concerned agencies, to ensure all hospitals within their respective administration to be equipped with sufficient/adequate means and logistics providing medical oxygen, vaccine and medical treatment to COVID patients with judicial accountability of all concerns which is possible only by way of appropriate orders/directions by this Court."



from Firstpost India Latest News https://ift.tt/3uRG3yK
Press Trust of India

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more